SIRT1 modulates MAPK pathways in ischemic-reperfused cardiomyocytes

Area of Science:

• Cardiovascular Biology
• Molecular Mechanisms of Disease
• Cellular Stress Response

Background:

• Sirtuin 1 (SIRT1) is a deacetylase involved in longevity and stress response, activated by reactive oxygen species (ROS).
• Resveratrol (Resv) activates SIRT1 and shows health benefits in oxidative stress-related diseases.
• The mitogen-activated protein kinase (MAPK) pathway is implicated in ischemia-reperfusion (IR) injury and stress responses.

Purpose of the Study:

• To investigate the protective effects of Resveratrol-induced SIRT1 activation in simulated IR injury in neonatal rat ventricular cardiomyocytes.
• To elucidate the relationship between SIRT1 activation and the MAPK pathway under IR conditions.

Main Methods:

• Neonatal rat ventricular cardiomyocytes were subjected to simulated ischemia-reperfusion (IR).
• The effects of Resveratrol (Resv) on SIRT1 activation, cardiomyocyte protection, and MAPK pathway signaling (p38, JNK, ERK phosphorylation) were assessed.
• Akt/ASK1 signaling was investigated as a mediator.

Main Results:

• Resveratrol-induced SIRT1 overexpression protected cardiomyocytes against IR-induced oxidative injury, mitochondrial dysfunction, and cell death.
• SIRT1 overexpression modulated the MAPK pathway by decreasing p38 and JNK phosphorylation.
• SIRT1 overexpression increased ERK phosphorylation, mediated via Akt/ASK1 signaling.

Conclusions:

• Resveratrol-induced SIRT1 activation provides a novel protective mechanism against ischemia-reperfusion injury in cardiac tissues.
• Modulation of the MAPK pathway by SIRT1 represents a key aspect of this protective effect.
• Targeting SIRT1 activation may offer new therapeutic avenues for managing IR-induced cardiac dysfunction.